References
- FriedmanHSKerbyTCalvertHTemozolomide and treatment of malignant gliomaClin Cancer Res2000672585259710914698
- BirnbaumTHildebrandtJNueblingGSostakPStraubeAGlioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitroJ Neurooncol20111051576521547397
- di TomasoESnuderlMKamounWSGlioblastoma recurrence after cediranib therapy in patients: lack of “rebound” revascularization as mode of escapeCancer Res2011711192821199795
- SmitsMNilssonJMirSEmiR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesisOncotarget20101871072021321380
- StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
- AgarwalSSaneROberoiROhlfestJRElmquistWFDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brainExpert Rev Mol Med201113e1721676290
- EstellerMGarcia-FoncillasJAndionEInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
- StuppRGanderMLeyvrazSNewlandsECurrent and future developments in the use of temozolomide for the treatment of brain tumoursLancet Oncol20012955256011905710
- HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
- YoshinoAOginoAYachiKGene expression profiling predicts response to temozolomide in malignant gliomasInt J Oncol20103661367137720428759
- WellerMTabatabaiGKästnerBMGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trialClin Cancer Res20152192057206425655102
- SrivenugopalKSYuanXHFriedmanHSAli-OsmanFUbiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-ben-zylguanine or 1,3-bis(2-chloroethyl)-1-nitrosoureaBiochemistry1996354132813348573590
- Esquela-KerscherASlackFJOncomirs: microRNAs with a role in cancerNat Rev Cancer20066425926916557279
- AkaoYNakagawaYNaoeTMicroRNAs 143 and 145 are possible common onco-microRNAs in human cancersOncol Rep200616484585016969504
- ChanJAKrichevskyAMKosikKSMicroRNA-21 is an antiapoptotic factor in human glioblastoma cellsCancer Res200565146029603316024602
- CowlandJBHotherCGrønbaekKMicroRNAs and cancerAPMIS2007115101090110618042145
- IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res200565167065707016103053
- WuLCaiCWangXLiuMLiXTangHMicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cellsFEBS Lett201158591322133021482222
- DengBZhangYZhangSWenFMiaoYGuoKMicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7Tumour Biol201536108065807325976503
- LeiZXuGWangLMiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancerFASEB J20142862696270424558198
- ChiouGYChienCSWangMLEpigenetic regulation of the miR-142-3p/interleukin-6 circuit in glioblastomaMol Cell201352569370624332177
- UjifukuKMitsutakeNTakakuraSmiR-195, miR-455-3p and miR-10a* are implicated in acquired temozolomide resistance in glioblastoma multiforme cellsCancer Lett2010296224124820444541
- PalanichamyJKRaoDSmiRNA dysregulation in cancer: towards a mechanistic understandingFront Genet201455424672539
- ShresthaAMukhametshinaRTTaghizadehSMicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and diseaseDev Dyn2017246428529027884048
- XiaoPLiuWLMiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinomaInt J Clin Exp Pathol201589108001080726617792
- ChenYZhouXQiaoJBaoAMiR-142-3p overexpression increases chemo-sensitivity of NSCLC by inhibiting HMGB1-mediated autophagyCell Physiol Biochem20174141370138228427045
- LiuKHuangJNiJMALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5pCell Cycle201716657858728346809
- XuGWangJJiaYShenFHanWKangYMiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1Cell Physiol Biochem20143351329133924803022
- ChenYHuFZhouYChenWShaoHZhangYMGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysisArch Med Res201344428129023608672
- GrimsonAFarhKKJohnstonWKGarrett-EngelePLimLPBartelDPMicroRNA targeting specificity in mammals: determinants beyond seed pairingMol Cell20072719110517612493
- JacksonALBurchardJSchelterJWidespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarityRNA20061271179118716682560
- LewisBPBurgeCBBartelDPConserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targetsCell20051201152015652477
- MathonnetGFabianMRSvitkinYVMicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4FScience200731758451764176717656684
- ChiSWZangJBMeleADarnellRBArgonaute HITS-CLIP decodes microRNA-mRNA interaction mapsNature2009460725447948619536157
- SeokHHamJJangESChiSWMicroRNA target recognition: insights from transcriptome-wide non-canonical interactionsMol Cells201639537538127117456
- FlamandMNGanHHMayyaVKGunsalusKCDuchaineTFA non-canonical site reveals the cooperative mechanisms of microRNA-mediated silencingNucleic Acids Res201745127212722528482037
- KhalilSFabbriESantangeloAmiRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastomaOncotarget2016719281952820627057640
- KushwahaDRamakrishnanVNgKA genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomasOncotarget2014124026403924994119
- AndaTShabaniHKTsunodaKRelationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysisNeurol Res200325324124812739231
- BrellMTortosaAVergerEPrognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomasClin Cancer Res200511145167517416033832
- GusyatinerOHegiMEGlioma epigenetics: from subclassification to novel treatment optionsSemin Cancer Biol Epub20171121
- BlancJLWagerMGuilhotJCorrelation of clinical features and methylation status of MGMT gene promoter in glioblastomasJ Neurooncol200468327528315332332
- SadonesJMichotteAVeldPMGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaEur J Cancer200945114615318945611
- TaylorJWSchiffDTreatment considerations for MGMT-unmethylated glioblastomaCurr Neurol Neurosci Rep201515150725394859
- LowSYHoYKTooHPYapCTNgWHMicroRNA as potential modulators in chemoresistant high-grade gliomasJ Clin Neurosci201421339540024411131